DAIICHI SANKYO CO., LTD. For Immediate Release
2017.02.24
Company name: DAIICHI SANKYO COMPANY, LIMITED
Representative: George Nakayama, Representative Director, President and CEO
(Code no.: 4568, First Section, Tokyo Stock Exchange)
Please address inquiries to Noriaki Ishida, Executive Officer,
Vice President, Corporate Communications Department
Telephone: +81-3-6225-1126
http://www.daiichisankyo.com
Daiichi Sankyo Appoints New Group Corporate Officers
TOKYO, Japan (February 24, 2017) - Daiichi Sankyo Company, Limited today announced the appointment of new Group corporate officers effective from April 1, 2017.
1. DAIICHI SANKYO CO., LTD.
Name | Current Responsibilities | New Responsibilities |
Toshiaki Sai | Member of the Board Senior Executive Officer Head of Corporate Strategy Div. | Member of the Board Senior Executive Officer Head of Global Brand Strategy Div. |
Noriaki Ishida | Executive Officer Vice President of Corporate Communications Dept., Corporate Management Div. | Executive Officer Vice President of Corporate Communications Dept., Corporate Strategy & Management Div. |
Junichi Koga | Executive Officer Head of R&D Div. and Vice President of Research Technology Function, and in charge of Biologics | Executive Officer Head of R&D Div. |
Yoshihiro Aoyagi | Corporate Officer Vice President of Legal Affairs Dept., General Affairs & Human Resources Div. | Executive Officer Head of Corporate Affairs Div. |
Yuichi Kubo | Corporate Officer Vice President of Business Development & Licensing Dept., Corporate Strategy Div. | Executive Officer Vice President of Business Development & Licensing Dept. |
Kentaro Takamura | Corporate Officer Vice President of Finance & Accounting Dept., Corporate Management Div. | Corporate Officer Vice President of Finance & Accounting Dept., Corporate Strategy & Management Div. |
Kenji Katsumi | Corporate Officer Vice President of Corporate Business Management Dept., Corporate Management Div. | Corporate Officer Vice President of Corporate Affairs & Procurement Dept., Corporate Affairs Div. |
Shinichi Tobita | Vice President of Marketing Dept., Sales & Marketing Div. | Corporate Officer Vice President of Marketing Dept., Sales & Marketing Div. |
Hironobu Furuta | Vice President of General Affairs & Procurement Dept., General Affairs & Human Resources Div. | Corporate Officer Vice President of Human Resources Dept., Corporate Affairs Div. |
Takeshi Hamaura | Vice President of CMC Planning Dept., Pharmaceutical Technology Div. | Corporate Officer Head of Pharmaceutical Technology Div. and Vice President of CMC Planning Dept. |
Hideyuki Hirano | Vice President of Sales Planning Dept., Sales & Marketing Div. | Corporate Officer Vice President of Sales Planning Dept., Sales & Marketing Div. |
Shoji Hirashima | Vice President of Corporate Strategy Dept. and Senior Director of Oncology Business Group, Corporate Strategy Div. | Corporate Officer Vice President of Corporate Business Management Dept., Corporate Strategy & Management Div. |
Koji Ogawa | Vice President of Business Planning Dept., ASCA Company | Corporate Officer President of ASCA Company |
◇Shuji Handa (current Executive Officer) will become Corporate Advisor as of April 1, 2017.
◇Norimasa Kamura (current Executive Officer) will become Corporate Advisor as of April 1, 2017.
◇Kazuo Sato (current Corporate Officer) will become Corporate Advisor as of April 1, 2017.
◇Naoyuki Kishi (current Corporate Officer) will be appointed the Member of the Board, DAIICHI SANKYO CHEMICAL PHARMA CO. LTD. as of April 1, 2017.
【Management structure as of April 1, 2017】
Position | Name | Responsibilities |
Representative Director, Chairman and CEO | George Nakayama | |
Representative Director, Member of the Board, President and COO | Sunao Manabe | |
Representative Director, Member of the Board, Executive Vice President and CFO | Kazunori Hirokawa | Head of Corporate Strategy & Management Div. |
Member of the Board, Senior Executive Officer | Toshiaki Sai | Head of Global Brand Strategy Div. |
Katsumi Fujimoto | Head of Supply Chain Div. | |
Toshiaki Tojo | In charge of Vaccine Business | |
Member of the Board (Outside) | Noritaka Uji | |
Hiroshi Toda | ||
Naoki Adachi | ||
Tsuguya Fukui | ||
Member of the Audit and Supervisory Board | Hideyuki Haruyama | |
Kazuyuki Watanabe | ||
Member of the Audit and Supervisory Board (Outside) | Akiko Kimura | |
Yutaka Katagiri | ||
Senior Executive Officer | Glenn Gormley | In charge of R&D |
Satoru Kimura | Head of Sales & Marketing Div. | |
Executive Officer | Noriaki Ishida | Vice President of Corporate Communications Dept., Corporate Strategy & Management Div. |
Ryoji Nagasaka | Vice President of Secretariat Dept. | |
Junichi Koga | Head of R&D Div. | |
Koichi Akahane | Vice President of Oncology Function, R&D Div. | |
Yoshihiro Aoyagi | Head of Corporate Affairs Div. | |
Yuichi Kubo | Vice President of Business Development & Licensing Dept. | |
Corporate Officer | Kohei Wada | Vice President of Development Function, R&D Div. |
Masahiko Ohtsuki | Vice President of Research Function, R&D Div. | |
Kentaro Takamura | Vice President of Finance & Accounting Dept., Corporate Strategy & Management Div. | |
Ryoichi Watanabe | Vice President of Internal Audit Dept. | |
Junichi Fukute | Vice President of Supply Chain Planning Dept., Supply Chain Div. | |
Kenji Katsumi | Vice President of Corporate Affairs & Procurement Dept., Corporate Affairs Div. | |
Kentaro Murakawa | Vice President of Tokyo Branch, Sales & Marketing Div. | |
Hirosumi Izawa | Head of Quality & Safety Management Div. | |
Shinichi Tobita | Vice President of Marketing Dept., Sales & Marketing Div. | |
Hironobu Furuta | Vice President of Human Resources Dept., Corporate Affairs Div. | |
Takeshi Hamaura | Head of Pharmaceutical Technology Div. and Vice President of CMC Planning Dept. | |
Hideyuki Hirano | Vice President of Sales Planning Dept. Sales & Marketing Div. | |
Shoji Hirashima | Vice President of Corporate Business Management Dept., Corporate Strategy & Management Div. | |
Koji Ogawa | President of ASCA Company |
2. DAIICHI SANKYO ESPHA CO., LTD.
Name | Current Responsibilities | New Responsibilities |
Shigeyoshi Obara | Vice President of Kyushu Branch, Sales & Marketing Div., DAIICHI SANKYO CO., LTD. | Member of the Board Deputy head of Sales & Marketing Div. |
3. KITASATO DAIICHI SANKYO VACCINE CO., LTD.
* Jun Hishida (current Executive Vice President) will retire on March 31, 2017.
Daiichi Sankyo Co. Ltd. published this content on 24 February 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 24 February 2017 01:08:02 UTC.
Original documenthttp://www.daiichisankyo.com/media_investors/media_relations/press_releases/detail/006591.html
Public permalinkhttp://www.publicnow.com/view/A99FE509536DDC31DE9C780AF446EF01991E471C
